Velan Capital Investment Management as of March 31, 2025
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 47 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 15.8 | $15M | 7.0M | 2.20 | |
| Acelyrin | 8.6 | $8.3M | 3.4M | 2.47 | |
| Springworks Therapeutics (SWTX) | 8.4 | $8.2M | 186k | 44.13 | |
| Protara Therapeutics Com Stk (TARA) | 7.3 | $7.1M | 1.7M | 4.26 | |
| Praxis Precision Medicines I Com New (PRAX) | 7.2 | $7.0M | 185k | 37.87 | |
| Tourmaline Bio (TRML) | 7.1 | $6.9M | 455k | 15.21 | |
| Jasper Therapeutics Com New (JSPR) | 6.3 | $6.2M | 1.4M | 4.30 | |
| Verona Pharma Sponsored Ads (VRNA) | 6.2 | $6.0M | 95k | 63.49 | |
| Zevra Therapeutics Com New (ZVRA) | 5.1 | $5.0M | 665k | 7.49 | |
| Liquidia Corporation Com New (LQDA) | 4.6 | $4.4M | 300k | 14.75 | |
| Inspiremd (NSPR) | 2.5 | $2.4M | 904k | 2.69 | |
| Scpharmaceuticals (SCPH) | 2.5 | $2.4M | 918k | 2.63 | |
| Mineralys Therapeutics (MLYS) | 2.5 | $2.4M | 151k | 15.88 | |
| Replimune Group (REPL) | 1.8 | $1.8M | 182k | 9.75 | |
| Edesa Biotech Com New (EDSA) | 1.7 | $1.7M | 688k | 2.44 | |
| Instil Bio Com New (TIL) | 1.2 | $1.2M | 69k | 17.36 | |
| Rezolute Com New (RZLT) | 1.2 | $1.2M | 400k | 2.90 | |
| Eledon Pharmaceuticals (ELDN) | 1.1 | $1.1M | 324k | 3.39 | |
| Perspective Therapeutics Com New (CATX) | 1.1 | $1.1M | 500k | 2.13 | |
| Geron Corporation (GERN) | 1.1 | $1.0M | 655k | 1.59 | |
| Immunome (IMNM) | 1.1 | $1.0M | 154k | 6.73 | |
| Tela Bio (TELA) | 0.9 | $912k | 747k | 1.22 | |
| Avalo Therapeutics Com New (AVTX) | 0.9 | $897k | 112k | 8.01 | |
| Sutro Biopharma (STRO) | 0.7 | $670k | 1.0M | 0.65 | |
| Upstream Bio (UPB) | 0.7 | $655k | 107k | 6.12 | |
| Tenax Therapeutics Com New (TENX) | 0.6 | $546k | 83k | 6.55 | |
| Kiora Pharmaceuticals (KPRX) | 0.4 | $368k | 122k | 3.01 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $313k | 59k | 5.31 | |
| Regulus Therapeutics | 0.1 | $140k | 80k | 1.75 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $105k | 13k | 8.08 | |
| Gossamer Bio (GOSS) | 0.1 | $83k | 75k | 1.10 | |
| Erasca (ERAS) | 0.1 | $69k | 50k | 1.37 | |
| Alector (ALEC) | 0.1 | $68k | 55k | 1.23 | |
| Larimar Therapeutics (LRMR) | 0.1 | $60k | 28k | 2.15 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $60k | 45k | 1.33 | |
| Context Therapeutics (CNTX) | 0.1 | $55k | 90k | 0.61 | |
| Design Therapeutics (DSGN) | 0.1 | $54k | 14k | 3.86 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $54k | 35k | 1.53 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $48k | 75k | 0.64 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $47k | 17k | 2.76 | |
| Ventyx Biosciences (VTYX) | 0.0 | $46k | 40k | 1.15 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $39k | 12k | 3.23 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $38k | 35k | 1.09 | |
| Ovid Therapeutics (OVID) | 0.0 | $30k | 97k | 0.31 | |
| Kronos Bio | 0.0 | $29k | 35k | 0.82 | |
| Nextcure (NXTC) | 0.0 | $12k | 25k | 0.48 | |
| Elevation Oncology (ELEV) | 0.0 | $12k | 45k | 0.26 |
